查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球左心室辅助装置 (LVAD) 市场 - 2023-2030 年
市场调查报告书
商品编码
1316287

全球左心室辅助装置 (LVAD) 市场 - 2023-2030 年

Global Left Ventricular Assist Device (LVAD) Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

2022 年，全球左心室辅助装置 (LVAD) 市场规模达到 14 亿美元，预计到 2030 年将实现利润丰厚的增长，达到 23 亿美元。在预测期内（2023-2030 年），全球左心室辅助装置 (LVAD) 市场的复合年增长率预计将达到 7.2%。

左心室辅助装置（VAD）是一种机械循环支持策略，通过将血液从心脏腔室泵送至全身，在心衰患者中广泛应用。预计在预测期内，心力衰竭人数的增加、新产品的推出、技术的进步和市场的不断发展等因素将推动全球左心室辅助装置（LVAD）市场的增长。

市场动态

心衰病例的增加推动了左心室辅助装置（LVAD）市场的增长。

预计在预测期内，心力衰竭病例的增加将推动全球左心室辅助装置市场的增长。心力衰竭极为典型。尽管在治疗多种心脏疾病方面取得了进展，但心力衰竭仍是全球日益关注的问题。例如，根据美国心力衰竭协会（Heart Failure Society of America）的评估，目前有近 650 万 20 岁以上的美国人患有心力衰竭。一项重要的调查评估显示，每年有超过 96 万名新的心力衰竭患者。心力衰竭不仅是一个影响相当多的人的重大问题，而且心力衰竭甚至是一个突出的杀手。在美国，心力衰竭直接导致的死亡人数约占所有心脏病死亡人数的 8.5%。据估计，心力衰竭导致的死亡人数约占心血管疾病死亡总人数的 36%。

研究活动的增加有望为全球左心室辅助装置（LVAD）市场带来增长机会。

越来越多的研究活动预计将推动全球左心室辅助装置市场的发展。例如，在确保获得 FDA 授权的首要行动中，总部位于以色列的设备制造商 Magenta Medical 正在对其用于高风险经皮冠状动脉介入治疗（HR-PCI）的 Elevate 经皮左心室辅助装置（pLVAD）启动一项不成熟的可行性调查。

预计在预测期内，高昂的左心室辅助装置植入费用将阻碍全球左心室辅助装置（LVAD）市场的发展。

据估计，在预测期内，植入左心室辅助装置的高昂费用将阻碍全球左心室辅助装置市场的发展。例如，根据美国国立卫生研究院（NIH）的数据，植入 LVAD 的平均费用为 175,420 美元。然而，LVAD 证明心力衰竭患者的生活质量得到了改善，但由于频繁的再入院和昂贵的后续护理，终生成本大幅增加。

COVID-19 影响分析

COVID-19 在全球许多国家的流行和封锁影响了各行各业公司的财务健康。因此，在 COVID-19 公共卫生紧急事件期间，美国食品和药物管理局 (FDA) 发布了指导方针，其中包括帮助申办者和研究人员的一般注意事项，以确保试验参与者的安全、遵守良好临床实践 (GCP)，并最大限度地降低试验完整性的风险。

俄乌战争影响分析

俄罗斯与乌克兰的冲突被认为对全球左心室辅助装置（LVAD）市场的影响不大，因为该地区的心力衰竭发病率较低，而且缺乏主要的市场参与者。尽管乌克兰军队继续抵御俄罗斯军队的入侵，但由于死亡人数不断增加，医疗援助有限，乌克兰的诊所也不得不这样做。所有类型的药品都出现短缺。同样，原材料进出口的重要性预计将在预测期内对全球左心室辅助装置（LVAD）市场的增长产生轻微影响。

目 录

第 1 章：研究方法与范围

  • 研究方法
  • 报告的研究目标和范围

第2章：定义和概述

第 3 章：执行摘要

  • 按类型摘录
  • 按泵类型划分
  • 按最终用户划分
  • 按区域划分

第四章：动态

  • 影响因素
    • 驱动因素
      • 越来越多的产品获得批准。
      • 心力衰竭发病率增长。
    • 制约因素
      • 成本高。
    • 机会
      • 研究活动日益增多
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情况
    • COVID-19 期间的情景
    • COVID-19 后的情况
  • COVID-19 期间的定价动态
  • 供求关系
  • 大流行期间与市场相关的政府倡议
  • 制造商的战略倡议
  • 结论

第 7 章：按类型划分

  • 经皮 LVAD
  • 植入式 LVAD
  • 其他类型

第 8 章：按泵类型

  • 第一代设备
  • 第二代设备
  • 第三代设备
  • 其他

第九章：按应用分类

  • 桥接康复（BTR）疗法
  • 桥接移植疗法（BTT）
  • 目的地疗法
  • 桥接治疗（BTC）
  • 其他疗法

第10章：按最终用户分类

  • 医院
  • 心脏病中心
  • 其他

第 11 章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
      • 亚太其他地区
  • 中东和非洲
    • 特定地区的主要动态

第 12 章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併与收购分析

第 13 章 ：公司简介

  • CorWave.
    • 公司概况
    • 类型组合和描述
    • 财务概况
    • 主要发展
  • Apaxis Inc.
  • Sunshine Heart.
  • HeartWare International (Medtronic)
  • Sun Medical Technology Research
  • Abiomed
  • Terumo Corporation
  • Evaheart
  • Jarvik Heart
  • Thoratec (Abbott)

第 14 章：附录

简介目录
Product Code: MD2890

Market Overview

The global left ventricular assist device (LVAD) market reached US$ 1.4 billion in 2022 and is expected to witness lucrative growth by reaching up to US$ 2.3 billion by 2030. The global left ventricular assist device (LVAD) market is expected to exhibit a CAGR of 7.2% during the forecast period (2023-2030).

Left Ventricular Assist Devices (VAD) are mechanical circulatory support strategies planted in heart failure individuals with intense manifestation and operation by pumping blood from the chambers of the heart to the entire body. The increase in the number of heart failures, rising type launches, advancements, and increasing market developments are among the factors expected to boost the global left ventricular assist device (LVAD) market growth in the forecast period.

Market Dynamics

Increasing Cases Of Heart Failure Drive The Growth Of The Left Ventricular Assist Device (LVAD) Market.

The increasing cases of heart failure are expected to boost the global left ventricle assist device market growth in the forecast period. Heart failure is extremely typical. Although improvement is created in the treatment of multiple states of heart conditions, heart failure is a growing concern globally. For instnace, according to the Heart Failure Society of America, the current assessments are that nearly 6.5 million Americans over the age of 20 suffer heart failure. One significant investigation assessment indicates that there are over 960,000 fresh heart failure patients yearly. Not only is heart failure a significant issue impacting a considerable number of individuals, but heart failure is even a prominent killer. Heart failure directly accounts for approximately 8.5% of all heart condition deaths in the United States. And, to some assessments, heart failure contributes to about 36% of all cardiovascular disease deaths.

The Increase in Research Activities is Expected To Present The Global Left Ventricular Assist Device (LVAD) Market With Growth Opportunities.

Increasing research initiatives are estimated to boost the global For instance, in the foremost action in ensuring FDA authorization, Israel-based device maker Magenta Medical is initiating a premature feasibility investigation with its Elevate percutaneous Left Ventricular Assist Device (pLVAD) for high-risk percutaneous coronary intervention (HR-PCI).

The High Cost of LVAD Implantation is Estimated To Hamper The Global Left Ventricular Assist Device (LVAD) Market During The Forecast Period.

The high cost of LVAD implantation is estimated to hamper the global left ventricular assist device market growth in the forecast period. For instance, according to the NIH, the mean cost of LVAD implantation was USD 175,420. However, LVADs proven heart failure patients improved quality of life but substantially increased lifetime costs because of frequent readmissions and costly follow-up care.

COVID-19 Impact Analysis

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is thought to hold a moderate influence on the global left ventricular assist device (LVAD) market, as there is a low incidence of heart failure and a lack of primary market players in this region. Though continuing to countenance invasions from Russian armies, Ukrainian clinics are forced by growing numbers of deaths and limited medical aid. There are shortages across all types of medications. Again, the significance of the import and export of raw materials are expected to slightly impact the global Left Ventricular Assist Device (LVAD) market growth in the forecast period.

Segment Analysis

The global left ventricular assist device (LVAD) market is segmented based on type, pump type, application, end-user, and region.

The Implantable LVAD Type is Estimated to Dominate the Global Left Ventricular Assist Device (LVAD) Market.

Owing to the increase in the procedures of implantable LVAD, implantable LVAD is estimated to hold around 23.9% of the global market share by 2030. For instnace, in July 2022, a team from Emory's Heart and Vascular Center conducted its 500th continuous flow, durable left ventricular assist device (LVAD) implantation, additionally establishing Emory Healthcare's position as a national leader in the life-saving procedure.

Geographical Analysis

Europe is Estimated to Hold 27.1% of the Market Share Owing to the Key Player's Efforts in this Region.

Owing to the key player's efforts in the Europe region, the region is estimated to hold around 27.1% of the global market share. For instance, UK-based Calon Cardio-Technology Ltd. seeks to obtain the CE Mark for its MiniVAD in earlier 2024, by which period a US FDA Early Feasibility Study is expected to have been concluded. The corporation pursues to boost investments of almost USD 47 million (£34 million) to USD 60 million (£43 million) to finance its clinical investigations of the MiniVAD in the US and Europe from 2020 to 2023.

Competitive Landscape

The major global players in the Left Ventricular Assist Device (LVAD) market include: CorWave, Apaxis Inc., Sunshine Heart, HeartWare International (Medtronic), Sun Medical Technology Research, Abiomed, Terumo Corporation, Evaheart, Jarvik Heart, and Thoratec (Abbott), among others.

Why Purchase the Report?

  • To visualize the global left ventricular assist device (LVAD) market segmentation based on type, pump type, application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of left ventricular assist device (LVAD) market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Type mapping available in Excel consisting of key Types of all the major players.

The global left ventricular assist device (LVAD) market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Pump Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Product Approvals.
      • 4.1.1.2. Growing Incidences of Heart Failure.
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost.
    • 4.1.3. Opportunity
      • 4.1.3.1. Increasing Research Activities
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Transcutaneous LVAD *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Implantable LVAD
  • 7.4. Others

8. By Pump Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pump Type
    • 8.1.2. Market Attractiveness Index, By Pump Type
  • 8.2. First-Generation Devices*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Second-Generation Devices
  • 8.4. Third-Generation Devices
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Bridge-to-Recovery (BTR) Therapy *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Bridge-to-Transplant (BTT) Therapy
  • 9.4. Destination Therapy
  • 9.5. Bridge-to-Candidacy (BTC) Therapy
  • 9.6. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Cardiology Centers
  • 10.4. Other

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pump Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pump Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pump Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pump Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan

Australia

      • 11.5.7.4. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pump Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. CorWave.*
    • 13.1.1. Company Overview
    • 13.1.2. Type Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Apaxis Inc.
  • 13.3. Sunshine Heart.
  • 13.4. HeartWare International (Medtronic)
  • 13.5. Sun Medical Technology Research
  • 13.6. Abiomed
  • 13.7. Terumo Corporation
  • 13.8. Evaheart
  • 13.9. Jarvik Heart
  • 13.10. Thoratec (Abbott)

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us